review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Samaranayake LP | |
Samaranayake YH | |||
P433 | issue | 5 | |
P921 | main subject | epidemiology | Q133805 |
Candida krusei | Q289229 | ||
emerging pathogen | Q108429945 | ||
P304 | page(s) | 295-310 | |
P577 | publication date | 1994-11-01 | |
P1433 | published in | Journal of Medical Microbiology | Q15708716 |
P1476 | title | Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. | |
P478 | volume | 41 |
Q37802257 | A Review of the Ultrastructural Features of Superficial Candidiasis |
Q39630911 | A monoclonal antibody specific to surface antigen on Candida krusei. |
Q73390114 | Adhesion of Candida albicans, but not Candida krusei, to salivary statherin and mimicking host molecules |
Q77758736 | Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents |
Q44259661 | Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin |
Q46601907 | Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model |
Q33749111 | Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance |
Q35752870 | Antifungals in systemic neonatal candidiasis |
Q95852835 | Antimicrobial Activities of New Indole Derivatives Containing 1,2,4-Triazole, 1,3,4-Thiadiazole and Carbothioamide |
Q73198861 | Bilateral endogenous Candida endophthalmitis and chorioretinitis following toxic megacolon |
Q34004133 | Candida albicans and Candida krusei differentially induce human blood mononuclear cell interleukin-12 and gamma interferon production |
Q90013376 | Candida biome of severe early childhood caries (S-ECC) and its cariogenic virulence traits |
Q38453829 | Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans |
Q28260910 | Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005 |
Q38028552 | Candida krusei: biotechnological potentials and concerns about its safety |
Q43839118 | Case report. Successful treatment of two cases of post-surgical sternal osteomyelitis, due to Candida krusei and Candida albicans, respectively, with high doses of triazoles (fluconazole, itraconazole). |
Q54312142 | Close association between oral Candida species and oral mucosal disorders in patients with xerostomia. |
Q39502192 | Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans |
Q40625997 | Comparison of PCR- and HinfI restriction endonuclease-based methods for typing of Candida krusei isolates. |
Q37352730 | Development of Candida-associated denture stomatitis: new insights |
Q58838532 | Emergence of Saccharomyces cerevisiae as a human pathogen |
Q37900678 | Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy. |
Q33975696 | Experimental oral candidiasis in animal models |
Q34988444 | High oral prevalence of Candida krusei in leprosy patients in northern Thailand. |
Q41783468 | Identification and Sequencing of Candida krusei Aconitate Hydratase Gene Using Rapid Amplification of cDNA Ends Method and Phylogenetic Analysis. |
Q35056809 | In Vitro and In Vivo Activities of Essential Oil from the Seed of Anethum graveolens L. against Candida spp. |
Q39830466 | In vitro Impact of Limited Exposure to Subtherapeutic Concentrations of Chlorhexidine Gluconate on the Adhesion-Associated Attributes of Oral Candida Species |
Q77931985 | In vitro activities of antimicrobial agents against Candida species |
Q41042117 | In vitro method to study antifungal perfusion in Candida biofilms |
Q64120011 | Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Pathogens |
Q73081254 | Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species |
Q58271063 | Oral Candidiasis and the Medically Compromised Patient |
Q34632651 | Oral candidal infections and antimycotics |
Q50053143 | Photodynamic antimicrobial chemotherapy (PACT) using toluidine blue inhibits both growth and biofilm formation by Candida krusei. |
Q24550528 | Prevention of yeast spoilage in feed and food by the yeast mycocin HMK |
Q44440005 | Rapid and cost-effective identification of Candida species using multipoint inoculation of CHROMagar Candida media, cycloheximide sensitivity and carbohydrate assimilation tests |
Q73864757 | Rare non-albicans Candida species detected in different clinical diagnoses |
Q59113063 | Recurring Events of Candida krusei Septicaemia: First Report from an ICU |
Q40172874 | Restriction enzyme analysis of ribosomal DNA shows that Candida inconspicua clinical isolates can be misidentified as Candida norvegensis with traditional diagnostic procedures. |
Q43753773 | Role of hydrophobicity in adhesion of wild yeast isolated from the ultrafiltration membranes of an apple juice processing plant |
Q77695984 | Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations |
Q36544229 | Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains. |
Q60047553 | Strong Synergism of Palmatine and Fluconazole/Itraconazole Against Planktonic and Biofilm Cells of Species and Efflux-Associated Antifungal Mechanism |
Q59113064 | The Anticandidal and Toxicity Properties of Lampranthus francisci |
Q46238781 | The Candida species that are important for the development of atrophic glossitis in xerostomia patients |
Q36718267 | The Comparison of vaginal cream of mixing yogurt, honey and clotrimazole on symptoms of vaginal candidiasis |
Q30501710 | The interaction between Candida krusei and murine macrophages results in multiple outcomes, including intracellular survival and escape from killing |
Q38261303 | Uncommon opportunistic fungal infections of oral cavity: A review |
Q37393878 | Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei |
Q41188065 | Update on invasive candidiasis |
Q38684199 | Whole Genome Sequence of the Heterozygous Clinical Isolate Candida krusei 81-B-5. |
Search more.